ConductScience.org, home

Paper39754657

APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway.

Du S and 7 others. Biochem Genet, 2026. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway. Papers, record 39754657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39754657

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway.
PubMed
Journal
Biochem Genet
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-02-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Du SShuangqiuhttps://orcid.org/0000-0002-2992-2653
2Wang JJingtong
3Liu MMiaomiao
4Liu RRong
5Wang HHui
6Zhang YYao
7Zhou FFengcang
8Pei WWenjunhttps://orcid.org/0000-0002-3106-3309

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Apolipoproteins MMajor topic
Liver NeoplasmsMajor topic
GlycolysisMajor topic
HexokinaseMajor topic
Receptors, NotchMajor topic
Humans
Signal Transduction
Gene Expression Regulation, Neoplastic
Cell Line, Tumor
Hep G2 Cells
Glucose

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
KJ2020A0612Scientific Research Foundation of Education Department of Anhui Province of ChinaPubMed
202310368006National College Students Innovation and Entrepreneurship Training ProgramPubMed
S202310368096Anhui college students innovation and entrepreneurship training program projectPubMed
LAB202202Anhui Provincial Key Laboratory of Bioactive Macromolecules Research Independent Research ProjectPubMed

Source PubMed

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134,149,930ApoM is an important potential protective factor in the pathogenesis of primary liver cancer.J Cancer2021https://conductscience.org/library/papers/34149930PubMed
237,236,409Therapeutic strategies targeting metabolic characteristics of cancer cells.Crit Rev Oncol Hematol2023https://conductscience.org/library/papers/37236409PubMed
335,158,779Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective.Cancers (Basel)2022https://conductscience.org/library/papers/35158779PubMed
435,289,308Targeting the vasculature in cardiometabolic disease.J Clin Invest2022https://conductscience.org/library/papers/35289308PubMed
538,572,751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
636,859,310m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion.Mol Cancer2023https://conductscience.org/library/papers/36859310PubMed
735,078,134UALCAN: An update to the integrated cancer data analysis platform.Neoplasia2022https://conductscience.org/library/papers/35078134PubMed
836,911,798The Function of Memory CD8+ T Cells in Immunotherapy for Human Diseases.Immune Netw2023https://conductscience.org/library/papers/36911798PubMed
935,682,918Roles of Notch Signaling in the Tumor Microenvironment.Int J Mol Sci2022https://conductscience.org/library/papers/35682918PubMed
1032,273,439Metabolic reprogramming and cancer progression.Science2020https://conductscience.org/library/papers/32273439PubMed
1132,872,164Fatty Acid Synthase: An Emerging Target in Cancer.Molecules2020https://conductscience.org/library/papers/32872164PubMed
1232,221,968The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis.Hepatology2021https://conductscience.org/library/papers/32221968PubMed
1335,144,601Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview.Cancer Cell Int2022https://conductscience.org/library/papers/35144601PubMed
1435,022,204Hallmarks of Cancer: New Dimensions.Cancer Discov2022https://conductscience.org/library/papers/35022204PubMed
1521,376,230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1630,610,087Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis.Cancer Res2019https://conductscience.org/library/papers/30610087PubMed
1733,194,645Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.Front Oncol2020https://conductscience.org/library/papers/33194645PubMed
1836,672,360Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review.Cancers (Basel)2023https://conductscience.org/library/papers/36672360PubMed
1932,863,941DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis.Theranostics2020https://conductscience.org/library/papers/32863941PubMed
2039,630,888Boosting 1H and 13C NMR signals by orders of magnitude on a bench.Sci Adv2024https://conductscience.org/library/papers/39630888PubMed

See all 47 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42,455,107Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights From Proteomic and Metabolomic Mediators.JACC CardioOncol2026https://conductscience.org/library/papers/42455107PubMed
42,161,914Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42161914PubMed
41,719,166ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.Sci Prog2026https://conductscience.org/library/papers/41719166PubMed
41,430,109Molecular regulatory network of glycolytic reprogramming in hepatocellular carcinoma and its clinical implications.Biol Proced Online2025https://conductscience.org/library/papers/41430109PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOM55,937PubTator's text mininghttps://conductscience.org/library/genes/55937NCBI Gene
HK23,099PubTator's text mininghttps://conductscience.org/library/genes/3099NCBI Gene
LDHA3,939PubTator's text mininghttps://conductscience.org/library/genes/3939NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39754657

GET https://conductscience.org/api/papers/v1/39754657/references?page=2